Health Challenge | Explanation |
Strain-Specific Efficacy | Not all probiotics have the same effects. The benefits of specific strain are complex; benefits can be strain or species specific and identifying the specific strain to treat an ailment requires rigorous clinical validity (Binda et al., 2020). |
Individual Variability | People have unique genetic programming, gut microbiota composition, and diets that alter how they respond to probiotics making it difficult a one fits all approach (Hughes et al., 2019). |
Low Survival in the GI Tract | Many probiotics are damaged or killed by stomach acid, bile or digestive enzymes before they reach the intestine. Therefore, without using a more advanced encapsulation or resilient strain, the effectiveness of many of probiotics will be very limited. (Jumazhanova et al., 2023). |
Temporary Effects | Often, the health benefits diminish after supplementation stops. This raises the need for continuous intake or dietary integration for long-term results (Brunin et al., 2022). |
Regulatory and Safety Issues | In many countries, probiotics are marketed as dietary supplements and not drugs. Regulation around dietary supplements are less stringent than regulations around drugs. Therefore, the inconsistency in composition and efficacy can vary tremendously (de Simone, 2019). |
Gut Microbiota Interference | Introducing new strains into an already balanced gut can disrupt the microbiome or fail to colonize. This highlights the importance of precision selection to avoid dysbiosis (Plaza-Diaz et al., 2019). |
Limited Evidence in Some Areas | While digestive benefits are well supported, more data is needed to confirm benefits for mental health, metabolic syndrome, and chronic diseases (Grajek et al., 2022). |
Probiotic-Prebiotic Interactions | Though prebiotics often enhance probiotic efficacy, their synergistic relationship remains under-researched. More studies are needed to optimize this combination in food systems (Li et al., 2020). |